DaShenLin Pharmaceutical Group Co., Ltd.
Shanghai Stock Exchange 603233.SS
DaShenLin Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023: 17.09%
DaShenLin Pharmaceutical Group Co., Ltd. Return on Equity (ROE) is 17.09% for the year ending December 31, 2023, a 2.53% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
DaShenLin Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 16.67%, a 15.45% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was 14.44%, a -26.78% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 19.73%, a 19.02% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2019 was 16.57%, a -5.29% change year over year.
Key data
| Date | Return on Equity (ROE) | Return on Capital Employed (ROCE) | Interest Coverage Ratio | Debt to Equity Ratio |
|---|
Market news
Loading...
Shanghai Stock Exchange: 603233.SS
| CEO | Mr. Guoqiang Ke |
| IPO Date | July 31, 2017 |
| Location | China |
| Headquarters | 410 Longxi Avenue |
| Employees | 45,466 |
| Sector | Health Care |
| Industries | |
Description
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
Key trends
Past 5 years
Similar companies
Shanghai M&G Stationery Inc.
USD 3.92
1.92%
Yifeng Pharmacy Chain Co., Ltd.
USD 3.33
0.92%
Autobio Diagnostics Co., Ltd.
USD 5.54
1.35%
LBX Pharmacy Chain Joint Stock Company
USD 2.19
4.03%
Asymchem Laboratories (Tianjin) Co., Ltd.
USD 10.09
5.71%
StockViz Staff
January 15, 2025
Any question? Send us an email